DURECT Corporation is a pharmaceutical company focused on the development of pharmaceutical systems based on its drug delivery platform technologies that treat chronic debilitating diseases and enable biotechnology products. These platform technologies include the SABER Delivery System (a versatile depot injectable useful for protein and small molecule delivery), the ORADUR sustained release oral gel-cap technology (an oral sustained release technology with several potential abuse deterrent properties), the DURIN Biodegradable Implant (drug-loaded implant system) and the MICORDUR Biodegradable Microparticulates (microspheres injectable system). DURECT also partners with pharmaceutical companies to develop and commercialize pharmaceutical products based on its technologies. DURECT has four disclosed ongoing development programs of which three are in collaboration with pharmaceutical partners. Products in development range from chronic pain and post-surgical pain to Alzheimer's disease.